AGI Dermatics marketing
This article was originally published in The Rose Sheet
Executive Summary
Bio-pharmaceutical laboratory appoints Rpr Marketing Communications as its U.S. agency of record for the Remergent Skincare line, citing in Jan. 9 announcement Rpr's "in-depth understanding of the beauty industry." The seven-SKU Remergent line features DNA enzymes delivered via pH-sensitive liposomes. Products include DNA Repair Formula serum, A.M. Moisture SPF 15, High Intensity SPF 30 and Barrier Repair Formula. "We look forward to generating stronger brand awareness for Remergent, focusing on the DNA science and technology behind the brand," founder Daniel B. Yarosh, Ph.D. says. Launched in 2006, Remergent is sold in doctors' offices nationwide...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.